THC Farmaceuticals Inc
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch F… Read more
THC Farmaceuticals Inc (CBDG) - Total Assets
Latest total assets as of June 2022: $2.78 Million USD
Based on the latest financial reports, THC Farmaceuticals Inc (CBDG) holds total assets worth $2.78 Million USD as of June 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
THC Farmaceuticals Inc - Total Assets Trend (2011–2023)
This chart illustrates how THC Farmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
THC Farmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (September 2023)
THC Farmaceuticals Inc's total assets of $2.78 Million consist of 0.6% current assets and 99.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.1% |
| Accounts Receivable | $14.70K | 0.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $633.53K | 23.1% |
| Goodwill | $1.01 Million | 36.7% |
Asset Composition Trend (2011–2023)
This chart illustrates how THC Farmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: THC Farmaceuticals Inc's current assets represent 0.6% of total assets in 2023, a decrease from 9.5% in 2011.
- Cash Position: Cash and equivalents constituted 0.1% of total assets in 2023, down from 6.3% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, a decrease from 66.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 36.7% of total assets.
THC Farmaceuticals Inc Competitors by Total Assets
Key competitors of THC Farmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
THC Farmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - THC Farmaceuticals Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, THC Farmaceuticals Inc generates $ 15.38 in net profit.
THC Farmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.12 | 0.62 | 0.59 |
| Quick Ratio | 1.12 | 0.62 | 0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $73.11K | $ -399.93K | $ -2.05 |
THC Farmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between THC Farmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.46 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -1.1% |
| Total Assets | $2.75 Million |
| Market Capitalization | $121.95 USD |
Valuation Analysis
Below Book Valuation: The market values THC Farmaceuticals Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: THC Farmaceuticals Inc's assets decreased by 1.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for THC Farmaceuticals Inc (2011–2023)
The table below shows the annual total assets of THC Farmaceuticals Inc from 2011 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-09-30 | $2.75 Million | -1.08% |
| 2022-09-30 | $2.78 Million | -0.70% |
| 2021-09-30 | $2.80 Million | +20.18% |
| 2020-09-30 | $2.33 Million | -8.14% |
| 2019-09-30 | $2.53 Million | -8.07% |
| 2018-09-30 | $2.75 Million | +57.22% |
| 2017-09-30 | $1.75 Million | -0.03% |
| 2016-09-30 | $1.75 Million | +3640086.92% |
| 2014-09-30 | $48.15 | -1.09% |
| 2013-09-30 | $48.68 | -99.91% |
| 2012-09-30 | $51.74K | -21.38% |
| 2011-09-30 | $65.81K | -- |